These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9371932)

  • 21. Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.
    Bethoux FA; Palfy DM; Plow MA
    Int J Rehabil Res; 2016 Jun; 39(2):134-9. PubMed ID: 26926380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set.
    Gijbels D; Dalgas U; Romberg A; de Groot V; Bethoux F; Vaney C; Gebara B; Medina CS; Maamâgi H; Rasova K; de Noordhout BM; Knuts K; Feys P
    Mult Scler; 2012 Mar; 18(3):364-71. PubMed ID: 21952098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures.
    Gijbels D; Alders G; Van Hoof E; Charlier C; Roelants M; Broekmans T; Eijnde BO; Feys P
    Mult Scler; 2010 May; 16(5):618-26. PubMed ID: 20207785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further validation of the Six-Spot Step Test as a measure of ambulation in multiple sclerosis.
    Sandroff BM; Motl RW; Sosnoff JJ; Pula JH
    Gait Posture; 2015 Jan; 41(1):222-7. PubMed ID: 25455207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid Use.
    Formica CA; Cosman F; Nieves J; Herbert J; Lindsay R
    Calcif Tissue Int; 1997 Aug; 61(2):129-33. PubMed ID: 9236259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test.
    Bowen J; Gibbons L; Gianas A; Kraft GH
    Mult Scler; 2001 Jun; 7(3):201-6. PubMed ID: 11475445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
    Noseworthy JH; Vandervoort MK; Wong CJ; Ebers GC
    Neurology; 1990 Jun; 40(6):971-5. PubMed ID: 2189084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of trunk impairment scale versions 1.0 and 2.0 in people with multiple sclerosis: A validation study.
    Nilsagård Y; Carling A; Davidsson O; Franzén L; Forsberg A
    Physiother Theory Pract; 2017 Oct; 33(10):772-779. PubMed ID: 28715271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
    Kahraman T; Savci S; Coskuner Poyraz E; Ozakbas S; Idiman E
    NeuroRehabilitation; 2016; 38(1):7-14. PubMed ID: 26889793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.
    Block VJ; Lizée A; Crabtree-Hartman E; Bevan CJ; Graves JS; Bove R; Green AJ; Nourbakhsh B; Tremblay M; Gourraud PA; Ng MY; Pletcher MJ; Olgin JE; Marcus GM; Allen DD; Cree BA; Gelfand JM
    J Neurol; 2017 Feb; 264(2):316-326. PubMed ID: 27896433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
    Kragt JJ; Nielsen IM; van der Linden FA; Uitdehaag BM; Polman CH
    Mult Scler; 2006 Dec; 12(6):782-6. PubMed ID: 17263007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of physical therapy in multiple sclerosis as measured with the modified fatigue impact scale and ambulation index: a retrospective study.
    Brichetto G; Rinaldi S; Spallarossa P; Battaglia MA; de Carvalho ML
    NeuroRehabilitation; 2013; 33(1):107-12. PubMed ID: 23949038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
    Kalron A; Nitzani D; Achiron A
    BMC Neurol; 2016 May; 16():70. PubMed ID: 27206921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does robot-assisted gait training improve ambulation in highly disabled multiple sclerosis people? A pilot randomized control trial.
    Pompa A; Morone G; Iosa M; Pace L; Catani S; Casillo P; Clemenzi A; Troisi E; Tonini A; Paolucci S; Grasso MG
    Mult Scler; 2017 Apr; 23(5):696-703. PubMed ID: 27486219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of functional exercise capacity, pulmonary function and respiratory muscle strength in patients with multiple sclerosis with different disability levels and healthy controls.
    Bosnak-Guclu M; Gunduz AG; Nazliel B; Irkec C
    J Rehabil Med; 2012 Jan; 44(1):80-6. PubMed ID: 22234321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of static balance in ambulatory persons with multiple sclerosis.
    Fry DK; Huang MH; Rodda BJ
    Int J Rehabil Res; 2016 Mar; 39(1):42-7. PubMed ID: 26579696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
    Lizrova Preiningerova J; Novotna K; Rusz J; Sucha L; Ruzicka E; Havrdova E
    J Neuroeng Rehabil; 2015 Feb; 12():14. PubMed ID: 25890382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.